These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
910 related articles for article (PubMed ID: 21358303)
1. "Pediatric-type" gastrointestinal stromal tumors in adults: distinctive histology predicts genotype and clinical behavior. Rege TA; Wagner AJ; Corless CL; Heinrich MC; Hornick JL Am J Surg Pathol; 2011 Apr; 35(4):495-504. PubMed ID: 21358303 [TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases. Miettinen M; Sobin LH; Lasota J Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146 [TBL] [Abstract][Full Text] [Related]
3. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases. Yamamoto H; Kojima A; Nagata S; Tomita Y; Takahashi S; Oda Y Am J Surg Pathol; 2011 Sep; 35(9):1287-95. PubMed ID: 21836495 [TBL] [Abstract][Full Text] [Related]
4. Loss of succinate dehydrogenase subunit B (SDHB) expression is limited to a distinctive subset of gastric wild-type gastrointestinal stromal tumours: a comprehensive genotype-phenotype correlation study. Doyle LA; Nelson D; Heinrich MC; Corless CL; Hornick JL Histopathology; 2012 Nov; 61(5):801-9. PubMed ID: 22804613 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic relevance of overexpressions of PKC-θ and DOG-1 and KIT/PDGFRA gene mutations in extragastrointestinal stromal tumors: a Korean six-centers study of 28 cases. Kim KH; Nelson SD; Kim DH; Choi KU; Kim SJ; Min KW; Jang KS; Paik SS; Oh YH; Chae SW; Sohn JH; Kim HJ; Cho YK; Kim BI; Park DI; Sohn CI; Oh S; Choi SH; Choi YJ; Woo HY; Park YL; Park SJ; Lee SH; Ryu S; DO SI; Kang G; Kim K; Cho YH; Pyo JS Anticancer Res; 2012 Mar; 32(3):923-37. PubMed ID: 22399613 [TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity. Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270 [TBL] [Abstract][Full Text] [Related]
7. The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated. Penzel R; Aulmann S; Moock M; Schwarzbach M; Rieker RJ; Mechtersheimer G J Clin Pathol; 2005 Jun; 58(6):634-9. PubMed ID: 15917417 [TBL] [Abstract][Full Text] [Related]
8. Multiple sporadic gastrointestinal stromal tumors (GISTs) of the proximal stomach are caused by different somatic KIT mutations suggesting a field effect. Agaimy A; Dirnhofer S; Wünsch PH; Terracciano LM; Tornillo L; Bihl MP Am J Surg Pathol; 2008 Oct; 32(10):1553-9. PubMed ID: 18724245 [TBL] [Abstract][Full Text] [Related]
9. Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size. Rossi S; Gasparotto D; Toffolatti L; Pastrello C; Gallina G; Marzotto A; Sartor C; Barbareschi M; Cantaloni C; Messerini L; Bearzi I; Arrigoni G; Mazzoleni G; Fletcher JA; Casali PG; Talamini R; Maestro R; Dei Tos AP Am J Surg Pathol; 2010 Oct; 34(10):1480-91. PubMed ID: 20861712 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes. Liegl B; Hornick JL; Corless CL; Fletcher CD Am J Surg Pathol; 2009 Mar; 33(3):437-46. PubMed ID: 19011564 [TBL] [Abstract][Full Text] [Related]
11. Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs. Martinho O; Gouveia A; Viana-Pereira M; Silva P; Pimenta A; Reis RM; Lopes JM Histopathology; 2009 Jul; 55(1):53-62. PubMed ID: 19614767 [TBL] [Abstract][Full Text] [Related]
12. Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior. Hornick JL; Fletcher CD Am J Surg Pathol; 2011 Feb; 35(2):190-201. PubMed ID: 21263239 [TBL] [Abstract][Full Text] [Related]
13. Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression. Liegl B; Hornick JL; Antonescu CR; Corless CL; Fletcher CD Am J Surg Pathol; 2009 Feb; 33(2):218-26. PubMed ID: 18830121 [TBL] [Abstract][Full Text] [Related]
14. Molecular alterations of KIT and PDGFRA in GISTs: evaluation of a Portuguese series. Gomes AL; Gouveia A; Capelinha AF; de la Cruz D; Silva P; Reis RM; Pimenta A; Lopes JM J Clin Pathol; 2008 Feb; 61(2):203-8. PubMed ID: 17827398 [TBL] [Abstract][Full Text] [Related]
15. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. Miettinen M; Wang ZF; Lasota J Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic consequences from molecular biology for gastrointestinal stromal tumor patients affected by neurofibromatosis type 1. Mussi C; Schildhaus HU; Gronchi A; Wardelmann E; Hohenberger P Clin Cancer Res; 2008 Jul; 14(14):4550-5. PubMed ID: 18628470 [TBL] [Abstract][Full Text] [Related]